Carolien Zeetsen

141 References R Bruijnen, C.J.W.H., Dijkstra, B.A.G., Walvoort, S.J.W., Markus, W., VanDerNagel, J.E.L., Kessels, R.P.C., & de Jong, C.A.J. (2019). Prevalence of cognitive impairment in patients with substance use disorder. Drug and Alcohol Review, 38 (4), 435–442. https://doi.org/10.111/dar.12922 Bruijnen, C.J.W.H., Jansen, M., Dijkstra, B.A.G., Walvoort, S.J.W., Lugtmeijer, S., Markus, W., de Jong, C.A.J., & Kessels, R.P.C. (2019). The Montreal Cognitive Assessment (MoCA) as a cognitive screen in addiction health care: a validation study for clinical practice. Journal of Substance Use, 24 (1), 47–54. https:// doi.org/10.1080/14659891.2018.1497102 Bruijnen, C.J.W.H., Kessels, R.P.C., Dijkstra, B.A.G., Walvoort, S.J.W., Wester, A.J., & de Jong, C.A.J. (2016). Montreal Cognitive Assessment – Dutch (MoCA–D): een cognitieve screener in de Nederlandse reguliere verslavingszorg [Montreal Cognitive Assessment (MoCA): a cognitive screen in addiction health care] (NISPA, Ed.). Nijmegen. Carter, L.P., Griffiths, R.R., & Mintzer, M.Z. (2009). Cognitive, psychomotor, and subjective effects of sodium oxybate and triazolam in healthy volunteers. Psychopharmacology, 206 , 141–154. https:// doi.org/10.1007/s00213-009-1589-1 Castelli, M.P., Mocci, I., Langlois, X., Gommeren, W., Luyten, W.H.M.L., Leysen, J.E., & Gessa, G.L. (2000). Quantitative autoradiographic distribution of g–Hydroxybutyric acid binding sites in human and monkey brain. Molecular Brain Research, 78 , 91–99. https://doi.org/10.1016/S0169-328X( 00)00078-4 Chelune, G.J., Naugle, R.I., Lüders, H., Sedlak, J., & Awad, I.A. (1993). Individual change after epilepsy surgery: practice effects and base–rate information. Neuropsychology, 7 (1), 41–52. https://doi. org/10.1037/0894-4105.7.1.41 Chertkow, H., Nasreddine, Z.S., Johns, E., Phillips, N., & McHenry, C. (2011). The Montreal Cognitive Assessment (MoCA): validation of alternate forms and new recommendations for education corrections. Alzheimer’s & Dementia, 7 (4, Supplement), S157. https://doi.org/10.1016/j. jalz.2011.05.423 Cicchetti, D.V. (1994). Guidelines, criteria, and rules of thumb for evaluating normed and standardized assessment instruments in psychology. Psychological Assessment, 6 (4), 284–290. https://doi. org/10.1037/1040-3590.6.4.284 Copersino, M.L., Fals–Stewart, W., Fitzmaurice, G., Schretlen, D.J., Sokoloff, J., & Weiss, R.D. (2009). Rapid cognitive screening of patients with substance use disorders. Experimental and Clinical Psychopharmacology, 17 (5), 337–344. https://doi.org/10.1037/a0017260 Copersino, M.L., Schretlen, D.J., Fitzmaurice, G.M., Lukas, S.E., Faberman, J., Sokoloff, J., & Weiss, R.D. (2012). Effects of cognitive impairment on substance abuse treatment attendance: predictive validation of a brief cognitive screening measure. American Journal of Drug and Alcohol Abuse, 38 (3), 246–250. https://doi.org/10.3109/00952990.2012.670866 Costa, A.S., Fimm, B., Friesen, P., Soundjock, H., Rottschy, C., Gross, T., Eitner, F., Reich, A., Schulz, J.B., Nasreddine, Z.S., & Reetz, K. (2012). Alternate–form reliability of the Montreal Cognitive Assessment screening test in a clinical setting. Dementia and Geriatric Cognitive Disorders, 33 , 379–384. https://doi.org/10.1159/000340006